Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 23:13:1033674.
doi: 10.3389/fphar.2022.1033674. eCollection 2022.

The role of IL-6 in coronavirus, especially in COVID-19

Affiliations
Review

The role of IL-6 in coronavirus, especially in COVID-19

Xinyi Wang et al. Front Pharmacol. .

Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects both people and animals and may cause significant respiratory problems, including lung illness: Corona Virus Disease 2019 (COVID-19). Swabs taken from the throat and nose of people who have the illness or are suspected of having it have shown this pathogenic virus. When SARS-CoV-2 infects the upper and lower respiratory tracts, it may induce moderate to severe respiratory symptoms, as well as the release of pro-inflammatory cytokines including interleukin 6 (IL-6). COVID-19-induced reduction of IL-6 in an inflammatory state may have a hitherto undiscovered therapeutic impact. Many inflammatory disorders, including viral infections, has been found to be regulated by IL-6. In individuals with COVID-19, one of the primary inflammatory agents that causes inflammatory storm is IL-6. It promotes the inflammatory response of virus infection, including the virus infection caused by SARS-CoV-2, and provides a new diagnostic and therapeutic strategy. In this review article, we highlighted the functions of IL-6 in the coronavirus, especially in COVID-19, showing that IL-6 activation plays an important function in the progression of coronavirus and is a rational therapeutic goal for inflammation aimed at coronavirus.

Keywords: COVID-19; IL-6; MERS; SARS; coronavirus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Comparison of IL-6 and other cytokines in healthy individual and SARS-CoV-2 infected people.
FIGURE 2
FIGURE 2
Changes of various immune cells and related substances in alveolus after SARS-CoV-2 invasion.
FIGURE 3
FIGURE 3
Macro and micro aspects of SARS-CoV-2 invading respiratory system.
FIGURE 4
FIGURE 4
Schematic diagram of SARS-CoV-2 structure.

References

    1. Akira S., Kishimoto T. (1992). IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol. Rev. 127, 25–50. 10.1111/j.1600-065x.1992.tb01407.x - DOI - PubMed
    1. Akira S., Taga T., Kishimoto T. (1993). Interleukin-6 in biology and medicine. Adv. Immunol. 54, 1–78. 10.1016/s0065-2776(08)60532-5 - DOI - PubMed
    1. Al-Qahtani A. A., Lyroni K., Aznaourova M., Tseliou M., Al-Anazi M. R., Al-Ahdal M. N., et al. (2017). Middle East respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ. Oncotarget 8 (6), 9053–9066. 10.18632/oncotarget.14754 - DOI - PMC - PubMed
    1. Bai B., Hu Q., Hu H., Zhou P., Shi Z., Meng J., et al. (2008). Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells. PLoS One 3 (7), e2685. 10.1371/journal.pone.0002685 - DOI - PMC - PubMed
    1. Baran P., Hansen S., Waetzig G. H., Akbarzadeh M., Lamertz L., Huber H. J., et al. (2018). The balance of interleukin (IL)-6, IL-6.soluble IL-6 receptor (sIL-6R), and IL-6.sIL-6R.sgp130 complexes allows simultaneous classic and trans-signaling. J. Biol. Chem. 293 (18), 6762–6775. 10.1074/jbc.RA117.001163 - DOI - PMC - PubMed